Company Description: SiNON has developed a patented tunable carbon nanoparticle that acts as a ‘Trojan horse' drug delivery platform that allows drugs to cross the blood brain barrier to treat many different neurological diseases. This allows our customers, the drug companies to encapsulate their therapeutics. Once the dot crosses the barrier the drug is released. This will allow companies to develop treatments with lower side effects and toxicity, which could dramatically improve the quality of life for millions of patients.